Annual Current Liabilities
$48.51 M
+$9.34 M+23.84%
December 31, 2023
Summary
- As of February 7, 2025, RCKT annual total current liabilities is $48.51 million, with the most recent change of +$9.34 million (+23.84%) on December 31, 2023.
- During the last 3 years, RCKT annual current liabilities has risen by +$15.89 million (+48.71%).
- RCKT annual current liabilities is now at all-time high.
Performance
RCKT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$39.98 M
+$2.39 M+6.35%
September 30, 2024
Summary
- As of February 7, 2025, RCKT quarterly total current liabilities is $39.98 million, with the most recent change of +$2.39 million (+6.35%) on September 30, 2024.
- Over the past year, RCKT quarterly current liabilities has increased by +$6.50 million (+19.43%).
- RCKT quarterly current liabilities is now -17.58% below its all-time high of $48.51 million, reached on December 31, 2023.
Performance
RCKT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RCKT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | +19.4% |
| 3 y3 years | +48.7% | +19.4% |
| 5 y5 years | +215.5% | +19.4% |
RCKT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +118.8% | -17.6% | +80.4% |
| 5 y | 5-year | at high | +164.9% | -17.6% | +118.4% |
| alltime | all time | at high | +1407.3% | -17.6% | +1530.5% |
Rocket Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $39.98 M(+6.4%) |
| Jun 2024 | - | $37.59 M(+14.1%) |
| Mar 2024 | - | $32.96 M(-32.1%) |
| Dec 2023 | $48.51 M(+23.8%) | $48.51 M(+44.9%) |
| Sep 2023 | - | $33.48 M(-2.5%) |
| Jun 2023 | - | $34.35 M(+10.1%) |
| Mar 2023 | - | $31.21 M(-20.3%) |
| Dec 2022 | $39.17 M(+76.7%) | $39.17 M(+29.8%) |
| Sep 2022 | - | $30.18 M(+24.3%) |
| Jun 2022 | - | $24.29 M(+7.6%) |
| Mar 2022 | - | $22.57 M(+1.8%) |
| Dec 2021 | $22.17 M(-32.0%) | $22.17 M(-9.5%) |
| Sep 2021 | - | $24.49 M(-3.8%) |
| Jun 2021 | - | $25.44 M(-37.2%) |
| Mar 2021 | - | $40.49 M(+24.1%) |
| Dec 2020 | $32.62 M(+78.1%) | $32.62 M(+2.1%) |
| Sep 2020 | - | $31.95 M(+54.5%) |
| Jun 2020 | - | $20.68 M(-2.0%) |
| Mar 2020 | - | $21.11 M(+15.3%) |
| Dec 2019 | $18.31 M | $18.31 M(-17.5%) |
| Sep 2019 | - | $22.18 M(+47.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $15.08 M(-26.7%) |
| Mar 2019 | - | $20.57 M(+33.8%) |
| Dec 2018 | $15.37 M(+277.7%) | $15.37 M(+49.3%) |
| Sep 2018 | - | $10.29 M(+1.5%) |
| Jun 2018 | - | $10.15 M(+38.3%) |
| Mar 2018 | - | $7.34 M(+80.3%) |
| Dec 2017 | $4.07 M(-42.2%) | $4.07 M(+8.0%) |
| Sep 2017 | - | $3.77 M(-6.2%) |
| Jun 2017 | - | $4.02 M(-23.8%) |
| Mar 2017 | - | $5.27 M(-25.2%) |
| Dec 2016 | $7.04 M(+70.1%) | $7.04 M(+18.5%) |
| Sep 2016 | - | $5.94 M(+46.0%) |
| Jun 2016 | - | $4.07 M(-11.8%) |
| Mar 2016 | - | $4.61 M(+11.4%) |
| Dec 2015 | $4.14 M(-42.7%) | $4.14 M(+27.7%) |
| Sep 2015 | - | $3.24 M(+32.3%) |
| Jun 2015 | - | $2.45 M(-0.2%) |
| Mar 2015 | - | $2.46 M(-66.0%) |
| Dec 2014 | $7.22 M(+124.4%) | $7.22 M(+31.4%) |
| Sep 2014 | - | $5.50 M(+70.8%) |
| Dec 2013 | $3.22 M(-14.5%) | $3.22 M |
| Dec 2012 | $3.77 M | - |
FAQ
- What is Rocket Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual current liabilities year-on-year change?
- What is Rocket Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly current liabilities year-on-year change?
What is Rocket Pharmaceuticals annual total current liabilities?
The current annual current liabilities of RCKT is $48.51 M
What is the all time high annual current liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual total current liabilities is $48.51 M
What is Rocket Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, RCKT annual total current liabilities has changed by +$9.34 M (+23.84%)
What is Rocket Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of RCKT is $39.98 M
What is the all time high quarterly current liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly total current liabilities is $48.51 M
What is Rocket Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, RCKT quarterly total current liabilities has changed by +$6.50 M (+19.43%)